PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $121,000 | -18.2% | 44,232 | +1.5% | 0.04% | -21.4% |
| Q3 2017 | $148,000 | +38.3% | 43,585 | +0.7% | 0.06% | +33.3% |
| Q2 2017 | $107,000 | +7.0% | 43,272 | -1.6% | 0.04% | +5.0% |
| Q1 2017 | $100,000 | +4.2% | 43,964 | -3.0% | 0.04% | +2.6% |
| Q4 2016 | $96,000 | -39.6% | 45,311 | -4.8% | 0.04% | -38.1% |
| Q3 2016 | $159,000 | +50.0% | 47,598 | +41.5% | 0.06% | +50.0% |
| Q2 2016 | $106,000 | -1.9% | 33,643 | +3.4% | 0.04% | -2.3% |
| Q1 2016 | $108,000 | 0.0% | 32,536 | +6.9% | 0.04% | 0.0% |
| Q4 2015 | $108,000 | -37.2% | 30,430 | -11.1% | 0.04% | -37.7% |
| Q3 2015 | $172,000 | -21.1% | 34,224 | +1.0% | 0.07% | -14.8% |
| Q2 2015 | $218,000 | -8.4% | 33,885 | +0.2% | 0.08% | -9.0% |
| Q1 2015 | $238,000 | -7.4% | 33,823 | +1.4% | 0.09% | -11.9% |
| Q4 2014 | $257,000 | +0.4% | 33,344 | -2.7% | 0.10% | +2.0% |
| Q3 2014 | $256,000 | -15.5% | 34,256 | +9.4% | 0.10% | -13.9% |
| Q2 2014 | $303,000 | +18.4% | 31,302 | +1.5% | 0.12% | +15.0% |
| Q1 2014 | $256,000 | – | 30,844 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |